Globus Pallidus Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The globus pallidus (GP) is a central nucleus of the Basal Ganglia that serves as a major relay in both the direct and indirect motor pathways. Comprising the external segment (GPe) and internal segment (GPi, functionally similar to SNr), these GABAergic neurons are critical for motor planning, selection, and execution. Their dysfunction underlies many movement disorders including Parkinson's disease, Huntington's disease, and dystonia.
The globus pallidus (GP) is a central nucleus of the basal ganglia that serves as a major relay station in the indirect motor pathway. It receives excitatory input from the subthalamic nucleus (STN) and inhibitory input from the striatum, and provides inhibitory output to the thalamus and subthalamic nucleus.
GP neurons are GABAergic projection neurons that help regulate movement. In Parkinson's disease, excessive GP activity contributes to motor symptoms, and surgical lesions or deep brain stimulation of the GP can improve parkinsonian symptoms.
Cell Type
GABAergic Projection Neuron
Neurotransmitter
GABA (γ-aminobutyric acid)
Brain Region
Basal Ganglia, Diencephalon
Marker Genes
GAD1, GAD2, PV (Parvalbumin), CR (Calretinin)
Key Afferents
Striatum (MSNs), STN, Cortex
Key Efferents
STN, SNr, Thalamus, Striatum
¶ Morphology and Markers
The globus pallidus contains two anatomically and functionally distinct segments:
- Cell type: Prototypic GABAergic neuron
- Marker genes: GAD1, GAD2, PV (parvalbumin), Calretinin
- Morphology: Large, aspiny neurons with extensive dendritic arborization
- Firing pattern: Irregular tonic firing, pause-responsive
- Cell type: Output GABAergic neuron (similar to SNr)
- Marker genes: GAD1, GAD2, PV
- Morphology: Large, spherical soma with long dendrites
- Firing pattern: High-frequency tonic firing
The globus pallidus is a central hub in the Basal Ganglia:
- Indirect pathway relay: Receives inhibitory input from indirect pathway MSNs
- STN modulation: Provides GABAergic inhibition to Subthalamic Nucleus
- Feedforward inhibition: Receives excitatory input from STN
- Network oscillations: Participates in beta-frequency synchronization
- Output nucleus: Provides inhibitory output to thalamus and brainstem
- Motor selection: Inhibits competing motor programs
- Movement termination: Helps terminate ongoing movements
- Pathway integration: Integrates direct and indirect pathway signals
- Primary neurotransmitter: GABA (inhibitory)
- Receptors: GABA_A and GABA_B receptors on target neurons
- Co-transmission: May co-release glycine in some projections
In Parkinson's disease, globus pallidus neurons exhibit significant changes:
- Increased firing rate: GPe and GPi firing increases due to reduced dopaminergic modulation
- Pattern disruption: Loss of burst firing and pathological oscillations
- Beta synchronization: Enhanced beta-frequency (13-30 Hz) oscillations
- Therapeutic target: GPi is a target for deep brain stimulation (DBS)
In Huntington's disease:
- Early loss: GPe neurons degenerate early in the disease
- Network dysfunction: Contributes to choreiform movements
- Circuit remodeling: Altered connectivity with striatal MSNs
Globus pallidus dysfunction is central to dystonia:
- GPi dysfunction: Abnormal GPi output leads to involuntary movements
- DBS target: GPi-DBS is an effective treatment for dystonia
- Pathophysiology: Impaired inhibition of thalamocortical circuits
Single-cell RNA sequencing reveals distinct populations within the GP:
- GAD1/GAD2: Universal markers of GABAergic neurons
- PV (Parvalbumin): Calcium-binding protein in fast-firing neurons
- CALB1 (Calbindin): Expressed in subset of neurons
- SST (Somatostatin): Marker for some GPe neurons
GPi is a primary target for Deep Brain Stimulation in:
- Parkinson's disease: Reduces tremor, bradykinesia, and dyskinesias
- Dystonia: Particularly effective for generalized dystonia
- Tourette syndrome: Reduces tic frequency and severity
- GABA agonists: Modulate GPi output
- Dopamine replacement: Indirectly normalizes GP activity
- Anticholinergics: Alter striatopallidal transmission
Globus pallidus neurons are essential components of the basal ganglia motor circuit, serving as critical integrators of direct and indirect pathway signals. Their vulnerability in Parkinson's disease, Huntington's disease, and dystonia makes them important therapeutic targets. The effectiveness of GPi deep brain stimulation underscores the clinical relevance of understanding globus pallidus function in neurodegenerative and movement disorders.
The study of Globus Pallidus Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
1. DeLong MR. Primate models of movement disorders of basal ganglia origin. *Trends Neurosci*. 1990;13(7):281-285. [DOI:10.1016/0166-2236(90](https://doi.org/10.1016/0166-2236(90))90110-V
2. Albin RL, et al. The functional anatomy of basal ganglia disorders. *Trends Neurosci*. 1989;12(10):366-375. [DOI:10.1016/0166-2236(89](https://doi.org/10.1016/0166-2236(89))90074-X
3. Bergman H, et al. Physiological aspects of information processing in the basal ganglia of normal and parkinsonian primates. *Trends Neurosci*. 1998;21(1):32-38. [DOI:10.1016/S0166-2236(97](https://doi.org/10.1016/S0166-2236(97))01151-X
4. Parent A, Hazrati LN. Functional anatomy of the basal ganglia. I. The cortico-striato-pallido-thalamo-cortical loop. *Brain Res Rev*. 1995;20(1):91-127. [DOI:10.1016/0165-0173(94](https://doi.org/10.1016/0165-0173(94))00007-C
5. Obeso JA, et al. Basal ganglia connections in normal and parkinsonian monkeys. *Neurobiol Dis*. 2012;48(3):329-339. [DOI:10.1016/j.nbd.2012.06.019](https://doi.org/10.1016/j.nbd.2012.06.019)
6. Galvan A, et al. What is the inhibitory output of the globus pallidus? *Nat Rev Neurosci*. 2014;15(12):787. [DOI:10.1038/nrn3839](https://doi.org/10.1038/nrn3839)
7. Vitek JL, et al. Globus pallidus internal segment discharge in parkinsonian patients. *J Neurophysiol*. 1999;82(2):1080-1085. [DOI:10.1152/jn.1999.82.2.1080](https://doi.org/10.1152/jn.1999.82.2.1080)
8. Krack P, et al. Deep brain stimulation: from neurology to psychiatry? *Trends Neurosci*. 2000;23(10):S40-S47. [DOI:10.1016/S1471-003X(00](https://doi.org/10.1016/S1471-003X(00))00050-5